Thc Therapeutics Stock Probability of Future Pink Sheet Price Finishing Under 0.001705
| THCT Stock | USD 0.0003 0.0001 50.00% |
THC |
THC Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of THC Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for THC Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| THC Therapeutics is way too risky over 90 days horizon | |
| THC Therapeutics has some characteristics of a very speculative penny stock | |
| THC Therapeutics appears to be risky and price may revert if volatility continues | |
| THC Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| THC Therapeutics currently holds 925.89 K in liabilities with Debt to Equity (D/E) ratio of 18.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. THC Therapeutics has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist THC Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, THC Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like THC Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for THC to invest in growth at high rates of return. When we think about THC Therapeutics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| THC Therapeutics currently holds about 3.82 K in cash with (388.48 K) of positive cash flow from operations. | |
| Roughly 31.0% of THC Therapeutics outstanding shares are owned by corporate insiders |
THC Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of THC Pink Sheet often depends not only on the future outlook of the current and potential THC Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. THC Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.6 M | |
| Cash And Short Term Investments | 296.1 K |
THC Therapeutics Technical Analysis
THC Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. THC Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of THC Therapeutics. In general, you should focus on analyzing THC Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
THC Therapeutics Predictive Forecast Models
THC Therapeutics' time-series forecasting models is one of many THC Therapeutics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary THC Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about THC Therapeutics
Checking the ongoing alerts about THC Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for THC Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| THC Therapeutics is way too risky over 90 days horizon | |
| THC Therapeutics has some characteristics of a very speculative penny stock | |
| THC Therapeutics appears to be risky and price may revert if volatility continues | |
| THC Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| THC Therapeutics currently holds 925.89 K in liabilities with Debt to Equity (D/E) ratio of 18.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. THC Therapeutics has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist THC Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, THC Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like THC Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for THC to invest in growth at high rates of return. When we think about THC Therapeutics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| THC Therapeutics currently holds about 3.82 K in cash with (388.48 K) of positive cash flow from operations. | |
| Roughly 31.0% of THC Therapeutics outstanding shares are owned by corporate insiders |
Additional Tools for THC Pink Sheet Analysis
When running THC Therapeutics' price analysis, check to measure THC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Therapeutics is operating at the current time. Most of THC Therapeutics' value examination focuses on studying past and present price action to predict the probability of THC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Therapeutics' price. Additionally, you may evaluate how the addition of THC Therapeutics to your portfolios can decrease your overall portfolio volatility.